ellipticine has been researched along with Liver Neoplasms in 2 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ellipticine treatment was found to result in the upregulation of p53, Fas/APO-1 receptor and Fas ligand." | 5.33 | Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. ( Cho, CY; Hsu, YL; Kuo, PL; Kuo, YC; Lin, CC, 2006) |
| "Ellipticine treatment was found to result in the upregulation of p53, Fas/APO-1 receptor and Fas ligand." | 1.33 | Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. ( Cho, CY; Hsu, YL; Kuo, PL; Kuo, YC; Lin, CC, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, RM | 1 |
| Ferreira, IC | 1 |
| Calhelha, RC | 1 |
| Lima, RT | 1 |
| Vasconcelos, MH | 1 |
| Adega, F | 1 |
| Chaves, R | 1 |
| Queiroz, MJ | 1 |
| Kuo, YC | 1 |
| Kuo, PL | 1 |
| Hsu, YL | 1 |
| Cho, CY | 1 |
| Lin, CC | 1 |
2 other studies available for ellipticine and Liver Neoplasms
| Article | Year |
|---|---|
Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Hepatocellular; Cell Cycle; Cell Prolif | 2011 |
Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; D | 2006 |